Cargando…

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a deadly form of liver cancer that has poor patient outcomes and survival. Unlike many other cancers, HCC has not seen the benefit of individualized treatment. Part of the reason HCC is hard to treat is due to differences among distinct regions of ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalasekar, Sharanya Maanasi, VanSant-Webb, Chad H., Evason, Kimberley J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582820/ https://www.ncbi.nlm.nih.gov/pubmed/34771685 http://dx.doi.org/10.3390/cancers13215524

Ejemplares similares

Heterogeneous beta-catenin activation is sufficient to cause hepatocellular carcinoma in zebrafish
por: Kalasekar, Sharanya M., et al.
Publicado: (2019)

Clinical implications of intratumor heterogeneity: challenges and opportunities
por: Ramón y Cajal, Santiago, et al.
Publicado: (2020)

Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma
por: VanSant-Webb, Chad, et al.
Publicado: (2023)

Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma
por: Kotiyal, Srishti, et al.
Publicado: (2021)

Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies
por: Zhang, Qi, et al.
Publicado: (2020)

Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
por: Xu, Fei-Qi, et al.
Publicado: (2023)

The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma
por: Li, Liu-Bo, et al.
Publicado: (2020)

Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
por: Wang, Yi, et al.
Publicado: (2023)

Intratumoral Morphologic and Molecular Heterogeneity of Rhabdoid Renal Cell Carcinoma: Challenges for Personalized Therapy
por: Singh, Rajesh R., et al.
Publicado: (2015)

Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC)
por: Buczak, Katarzyna, et al.
Publicado: (2018)

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma
por: Coto-Llerena, Mairene, et al.
Publicado: (2022)

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
por: Pardee, Angela D., et al.
Publicado: (2012)

Intratumoral Heterogeneity in Lung Cancer
por: Lv, Xiaodi, et al.
Publicado: (2023)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Clinical significance of intratumor heterogeneity for gynecological carcinoma
por: Yang, Ying-Chao, et al.
Publicado: (2015)

Hepatocellular Carcinoma in Africa: Challenges and Opportunities
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

The significance of intertumor and intratumor heterogeneity in liver cancer
por: Liu, Jinping, et al.
Publicado: (2018)

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
por: Huang, Jian-Hang, et al.
Publicado: (2022)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
por: Lu, Chen, et al.
Publicado: (2019)

Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
por: Sas, Zuzanna, et al.
Publicado: (2022)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Visualizing Human Colorectal Cancer Intratumor Heterogeneity with Phylogeography
por: Shibata, Darryl
Publicado: (2020)

Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Unifying models of glioblastoma’s intratumoral heterogeneity
por: Lam, K H Brian, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges
por: Hu, Chen, et al.
Publicado: (2023)

Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally
por: Wolf, Yochai, et al.
Publicado: (2022)

HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept
por: Hou, Yanjun, et al.
Publicado: (2023)

Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
por: Huang, Ao, et al.
Publicado: (2016)

Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
por: Krause, Jenny, et al.
Publicado: (2020)

Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma
por: Liang, Jialu, et al.
Publicado: (2022)

Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation
por: Jayant, Kumar, et al.
Publicado: (2020)

Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities
por: Christou, Chrysanthos D, et al.
Publicado: (2022)

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p6bi98s55jor87t5gjj9b90bna